Extracorporeal Blood Purification Therapy in Critically Ill Patients (GlobalARRT)
Recruiting
Observational Study
Critical Illness
Acute Kidney Injury
Sepsis
Systemic Inflammatory Response Syndrome
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,000 (estimated)
- Sponsor
- Careggi Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Worldwide, the use of Extracorporeal Blood Purification (EBP) in everyday clinical practice is becoming increasingly common, particularly in critical care settings. The efficacy of most of these treatments on removal of inflammatory mediators is the main rationale behind the use of EBP in critically ill patients with multiorgan dysfunction. Nonetheless, there are still some doubts as to the clinic…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria: patients who meet all the following inclusion criteria may be included in this study:
1. Admission to ICU
2. Indications for at least one of the following extracorporeal blood purification treatments:
1. Continuous Renal Replacement Therapy (CRRT) / Intermittent Hemodialysis…
Contacts